Hansoh Pharmaceutical Group Company Limited（03692.HK）股价、图表、新闻与AI分析

Q: Hansoh Pharmaceutical Group Company Limited 的 CEO 是谁？

Ms. Huijuan Zhong 是 Hansoh Pharmaceutical Group Company Limited 的 Executive Chairlady of the Board，自 2015 加入公司。

Q: HANSOH PHARMA 股票的价格表现如何？

HANSOH PHARMA 的当前价格为 $40.22，在上个交易日 下降 了 0.64%。

Q: Hansoh Pharmaceutical Group Company Limited 的主要业务主题或行业是什么？

Hansoh Pharmaceutical Group Company Limited 属于 Pharmaceuticals 行业，该板块是 Health Care

Q: Hansoh Pharmaceutical Group Company Limited 的市值是多少？

Hansoh Pharmaceutical Group Company Limited 的当前市值是 $239.1B

主页

股票

03692.HK

HANSOH PHARMA (03692.HK)

Hansoh Pharmaceutical Group Company Limited

HK$40.22

-0.64%

$-0.25

午间休市：Jan 22, 16:00:00 HKT

360

报告

A+

最终得分

关键数据

前收盘价

$40.5

开盘价

$40.48

当日区间

$40.16 - $41.2

52周范围

$15.96 - $44.22

交易量

1.9M

平均成交量

7.8M

每股收益（TTM）

0.89

股息收益率

市值

$239.1B

什么是 HANSOH PHARMA？

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.

功能特性

交易策略